Pasithea Therapeutics Corp (KTTA)

Mar 03, 2026

Earnings Recap: Whats the beta of Pasithea Therapeutics Corp stockMarket Risk Report & Daily Growth Stock Investment Tips - baoquankhu1.vn

Mar 03, 2026

Mar 03, 2026

Fed Watch: Whats the beta of Pasithea Therapeutics Corp Equity Warrant stockIPO Watch & Fast Entry High Yield Tips - baoquankhu1.vn

Mar 03, 2026

Mar 02, 2026

Certain Options of Pasithea Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 3-MAR-2026. - marketscreener.com

Mar 02, 2026

Feb 28, 2026

KTTA PE Ratio & Valuation, Is KTTA Overvalued - Intellectia AI

Feb 28, 2026

Feb 28, 2026

KTTA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Feb 28, 2026

Feb 27, 2026

Coastlands entities hold 2.39M shares in Pasithea Therapeutics (NASDAQ: KTTA) - Stock Titan

Feb 27, 2026

Feb 26, 2026

KTTA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 26, 2026

Feb 25, 2026

Breakout Move: Is Pasithea Therapeutics Corp Equity Warrant impacted by rising ratesPortfolio Return Summary & Comprehensive Market Scan Reports - baoquankhu1.vn

Feb 25, 2026

Feb 20, 2026

What’s next for Pasithea Therapeutics Corp. stockTrade Entry Report & AI Enhanced Execution Alerts - mfd.ru

Feb 20, 2026

Feb 20, 2026

Pasithea Therapeutics Receives Nasdaq Minimum Bid Price Notice - TipRanks

Feb 20, 2026

Feb 20, 2026

Pasithea Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Feb 20, 2026

Feb 17, 2026

CVI and Heights disclose 3.8% Pasithea (KTTA) stake via warrant holdings - Stock Titan

Feb 17, 2026

Feb 17, 2026

Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - Investing News Network

Feb 17, 2026

Feb 17, 2026

Pasithea Therapeutics Corp. to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 26, 2026 - Quiver Quantitative

Feb 17, 2026

Feb 17, 2026

NF1-PN drug developer Pasithea to present at Oppenheimer event - Stock Titan

Feb 17, 2026

Feb 15, 2026

Can Pasithea Therapeutics Corp. disrupt its industryQuarterly Market Summary & Daily Stock Trend Reports - mfd.ru

Feb 15, 2026

Feb 14, 2026

KTTA Should I Buy - Intellectia AI

Feb 14, 2026

Feb 12, 2026

Published on: 2026-02-12 18:27:19 - mfd.ru

Feb 12, 2026

Feb 12, 2026

Aug Mood: How does Pasithea Therapeutics Corp. correlate with NasdaqJuly 2025 Setups & Smart Investment Allocation Tips - mfd.ru

Feb 12, 2026

Feb 11, 2026

Published on: 2026-02-12 00:18:47 - mfd.ru

Feb 11, 2026

Feb 11, 2026

Why Pasithea Therapeutics Corp. stock is seen as undervaluedTrade Analysis Summary & AI Forecast for Swing Trade Picks - mfd.ru

Feb 11, 2026

Feb 11, 2026

What’s the beta of Pasithea Therapeutics Corp. stockWeekly Trading Summary & Precise Buy Zone Identification - mfd.ru

Feb 11, 2026

Feb 11, 2026

Why Pasithea Therapeutics Corp. Equity Warrant stock could be next big winnerJuly 2025 Price Swings & Daily Market Momentum Tracking - mfd.ru

Feb 11, 2026

Feb 10, 2026

Earnings Miss: Is Pasithea Therapeutics Corp Equity Warrant stock overvalued or fairly pricedJuly 2025 Trends & Capital Efficiency Focused Strategies - baoquankhu1.vn

Feb 10, 2026

Feb 08, 2026

Dividend Watch: What is the Moat Score of Pasithea Therapeutics Corp Equity WarrantGDP Growth & Stock Market Timing Techniques - baoquankhu1.vn

Feb 08, 2026

Feb 06, 2026

Pasithea Therapeutics Corp. (KTTA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Feb 06, 2026

Feb 04, 2026

Aug Levels: Can Pasithea Therapeutics Corp disrupt its industryWeekly Loss Report & Weekly High Momentum Picks - baoquankhu1.vn

Feb 04, 2026

Feb 04, 2026

Meme Stocks: Can Beyond Meat Inc. navigate macro headwindsRate Cut & Weekly Sector Rotation Insights - baoquankhu1.vn

Feb 04, 2026

Feb 02, 2026

Jobs Data: What is the long term forecast for Pasithea Therapeutics Corp stockJuly 2025 Fed Impact & Long-Term Safe Investment Plans - baoquankhu1.vn

Feb 02, 2026

Feb 02, 2026

Weekly Earnings: Can Pasithea Therapeutics Corp disrupt its industryQuarterly Trade Review & Growth-Oriented Investment Plans - baoquankhu1.vn

Feb 02, 2026

Feb 01, 2026

Institution Moves: Can Alerus Financial Corporation withstand a market correctionBond Market & Daily Entry Point Trade Alerts - baoquankhu1.vn

Feb 01, 2026

Jan 29, 2026

Is Pasithea Therapeutics Corp. stock influenced by commodity prices2025 Historical Comparison & Consistent Profit Trading Strategies - Mfd.ru

Jan 29, 2026

Jan 28, 2026

Pasithea Therapeutics Shareholders Approve Expanded Equity Authorization - TipRanks

Jan 28, 2026

Jan 28, 2026

Fundamentals Check: Is POET benefiting from innovation trends2025 Key Highlights & Accurate Intraday Trade Tips - baoquankhu1.vn

Jan 28, 2026

Jan 25, 2026

Performance Recap: Should I average down on WRAP stockMarket Movers & Fast Exit and Entry Strategy Plans - baoquankhu1.vn

Jan 25, 2026

Jan 25, 2026

Aug Shorts: Can Pasithea Therapeutics Corp sustain earnings growth2025 Bull vs Bear & Fast Gaining Stock Strategy Reports - baoquankhu1.vn

Jan 25, 2026

Jan 24, 2026

How does SWVL compare to its peersEarnings Recap Summary & High Yield Stock Recommendations - baoquankhu1.vn

Jan 24, 2026

Jan 22, 2026

Published on: 2026-01-22 13:20:30 - baoquankhu1.vn

Jan 22, 2026

Jan 16, 2026

Aug Big Picture: Is Finward Bancorp benefiting from interest rate changes2025 Investor Takeaways & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn

Jan 16, 2026

Jan 15, 2026

Pasithea Therapeutics regains Nasdaq compliance - MSN

Jan 15, 2026

Jan 14, 2026

New Highs: Can Pasithea Therapeutics Corp grow without external fundingJuly 2025 Closing Moves & Breakout Confirmation Trade Signals - baoquankhu1.vn

Jan 14, 2026

Jan 14, 2026

Pasithea Therapeutics: Buy Rating on Differentiated PAS-004, 2026 Clinical Catalysts, and Strengthened Cash Runway - TipRanks

Jan 14, 2026

Jan 14, 2026

Pasithea provides updates on clinical trials for MEK inhibitor drug By Investing.com - Investing.com Canada

Jan 14, 2026

Jan 13, 2026

Pasithea provides updates on clinical trials for MEK inhibitor drug - Investing.com

Jan 13, 2026

Jan 13, 2026

Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines - Investing News Network

Jan 13, 2026

Jan 13, 2026

Pasithea Therapeutics Updates Clinical Trial Timelines for PAS-004 in Neurofibromatosis and Advanced Cancer - Quiver Quantitative

Jan 13, 2026

Jan 10, 2026

Pasithea Therapeutics (NASDAQ:KTTA) Stock Rating Upgraded by Wall Street Zen - Defense World

Jan 10, 2026

Jan 09, 2026

How Pasithea Therapeutics Corp. Equity Warrant stock reacts to oil pricesJuly 2025 EndofMonth & Stepwise Trade Execution Plans - ulpravda.ru

Jan 09, 2026

Jan 09, 2026

How analysts rate Pasithea Therapeutics Corp. stock today2025 Trade Ideas & Weekly Chart Analysis and Trade Guides - ulpravda.ru

Jan 09, 2026

Jan 08, 2026

Why hedge funds are buying Pasithea Therapeutics Corp. stock2025 Momentum Check & Verified Swing Trading Watchlists - ulpravda.ru

Jan 08, 2026